Print Page   |   Contact Us   |   Your Cart   |   Sign In   |   Join
News & Press: State Legislation

Pharmacy Commission Bans Fentanyl Derivatives Not Approved by FDA and Other Synthetic Sustances

Monday, August 28, 2017   (0 Comments)
Posted by: Janet Anderson
Share |

The Pharmacy Quality Assurance Commission is adopting a new emergency rule to add fentanyl derivatives not approved by the Food and Drug Administration (FDA), synthetic cannabinoids, synthetic cathinones, and synthetic opioids to Schedule I under the Controlled Substance Act (CSA) continuing to make it illegal to sell, possess, manufacture, or deliver chemicals or products containing the substances. This emergency rule supersedes WSR 17-17-055 filed on Friday, August 11, 2017. A new emergency rule is needed because there were two significant errors in the first filing.

 

The descriptions of both synthetic cathinones and synthetic opioids to be scheduled refer to synthetic cannabinoids. Section 2(c) and 2(d) of the emergency rule language have been updated to have the proper descriptions of synthetic cathinones and synthetic opioids respectively. 

 

This Emergency Rule is effective immediately upon filing - WSR# 17-17-144 - Filing date/time 08/22/20173:47 PM 


more Calendar

9/27/2017
Webinar: Navigating the Communication Gap: Health Literacy in Pediatrics

10/5/2017
Suicide Awareness and Referral for Pharmacy Professionals

10/5/2017
Suicide Awareness and Referral for Pharmacy Professionals

Online Surveys
1402 - ICU Medical Inc Campaign
Association Management Software Powered by YourMembership  ::  Legal